Knockdown of EPHA2 in ESCC cell line TE8 resulted in significant decrease in cell proliferation and invasion, suggesting it is a promising therapeutic target in ESCC that warrants further evaluation. The gene discussed is EPHA2; the disease is esophageal squamous cell carcinoma.